Vir Biotechnology, Inc.
VIRAs of the close on Sep 25, 2026
Price
$10.66
Market cap
$1.8B
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Vir Biotechnology, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 9 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 10, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| EverSource Wealth Advisors, LLC | 2026-03-31 | 1,544 | $13.8K | SEC filing |
| Campbell & CO Investment Adviser LLC | 2026-03-31 | 10,369 | $92.9K | SEC filing |
| Squarepoint Ops LLC | 2026-03-31 | 26,013 | $233K | SEC filing |
| BIT Capital GmbH | 2026-03-31 | 30,000 | $269K | SEC filing |
| RHUMBLINE ADVISERS | 2026-03-31 | 232,550 | $2.08M | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 5,141 | $46.1K | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 985,435 | $8.83M | SEC filing |
| FEDERATED HERMES, INC. | 2026-03-31 | 4,739 | $42.5K | SEC filing |
| SG Americas Securities, LLC | 2026-03-31 | 20,284 | Not shown | SEC filing |
| DIMENSIONAL FUND ADVISORS LP | 2026-03-31 | 2,579,678 | $23.1M | SEC filing |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 2026-03-31 | 25,319 | $229K | SEC filing |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2026-03-31 | 43,338 | $388K | SEC filing |
| MAI Capital Management | 2026-03-31 | 504 | $4.52K | SEC filing |
| ALGERT GLOBAL LLC | 2026-03-31 | 489,008 | Not shown | SEC filing |
| FIFTH THIRD BANCORP | 2026-03-31 | 26,324 | $236K | SEC filing |
| Mariner, LLC | 2026-03-31 | 36,037 | $323K | SEC filing |
| Ikarian Capital, LLC | 2026-03-31 | 293,258 | $2.63M | SEC filing |
| Versant Capital Management, Inc | 2026-03-31 | 2,899 | $26K | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 1,078,020 | $9.66M | SEC filing |
- Each value is checked against Vir Biotechnology, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Vir Biotechnology, Inc.'s share price.
- 1 row left out: the value per share it reports is far from Vir Biotechnology, Inc.'s share prices on file from around the report date, far from the value most filers reported for that date, or the value of a security already left out, so it may describe another security or share class.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Vir Biotechnology, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-03-23 · Sabatini Brent: Larger than 19 of the 20 other insider sales of Common Stock on file. SEC filing
- 2026-02-25 · de Verneuil Vanina: Larger than all 20 other insider sales of Common Stock on file. SEC filing
- 2025-12-01 · SB INVESTMENT ADVISERS (UK) LTD: Larger than 90 of the 97 other insider sales of Common Stock on file. SEC filing
- 2025-11-25 · SB INVESTMENT ADVISERS (UK) LTD: Larger than 93 of the 97 other insider sales of Common Stock on file. SEC filing
- 2025-11-24 · SB INVESTMENT ADVISERS (UK) LTD: Larger than 92 of the 97 other insider sales of Common Stock on file. SEC filing
- 2025-10-23 · SB INVESTMENT ADVISERS (UK) LTD: Larger than 89 of the 97 other insider sales of Common Stock on file. SEC filing
- 2025-10-20 · SB INVESTMENT ADVISERS (UK) LTD: Larger than 91 of the 97 other insider sales of Common Stock on file. SEC filing
- 2025-10-09 · SB INVESTMENT ADVISERS (UK) LTD: Larger than 94 of the 97 other insider sales of Common Stock on file. SEC filing
- 2025-10-08 · SB INVESTMENT ADVISERS (UK) LTD: Larger than all 97 other insider sales of Common Stock on file. SEC filing
- 2025-10-03 · SB INVESTMENT ADVISERS (UK) LTD: Larger than 96 of the 97 other insider sales of Common Stock on file. SEC filing
- 2025-02-26 · de Verneuil Vanina: Larger than 18 of the 20 other insider sales of Common Stock on file. SEC filing
- 2023-05-23 · SB INVESTMENT ADVISERS (UK) LTD: Larger than 88 of the 97 other insider sales of Common Stock on file. SEC filing
- 2023-04-21 · SB INVESTMENT ADVISERS (UK) LTD: Larger than 95 of the 97 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-01 | Napolitano Janet · Director | Common Stock | S — Open market or private sale | −3,200 | 9.45 | SEC filing |
| 2026-06-01 | Sabatini Brent · SVP, Chief Accounting Officer | Common Stock | S — Open market or private sale | −379 | 9.45 | SEC filing |
| 2026-05-01 | SATO VICKI L · Director | Common Stock | S — Open market or private sale | −22,000 | 10.05 | SEC filing |
| 2026-04-06 | De Backer Marianne · President and CEO | Common Stock | S — Open market or private sale | −72,559 | 9.16 | SEC filing |
| 2026-04-01 | SATO VICKI L · Director | Common Stock | S — Open market or private sale | −22,000 | 9.07 | SEC filing |
| 2026-03-23 | Sabatini Brent · SVP, Chief Accounting Officer | Common Stock | S — Open market or private sale | −7,711 | 9.12 | SEC filing |
| 2026-03-02 | SATO VICKI L · Director | Common Stock | S — Open market or private sale | −200 | 9.98 | SEC filing |
| 2026-03-02 | SATO VICKI L · Director | Common Stock | S — Open market or private sale | −21,800 | 9.50 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-09 | Coughlin Timothy · Director | Common Stock | A — Grant, award, or other acquisition | +8,000 | SEC filing |
| 2026-06-09 | Coughlin Timothy · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +16,000 | SEC filing |
| 2026-05-27 | Farid Ramy · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +16,000 | SEC filing |
| 2026-05-27 | Napolitano Janet · Director | Common Stock | A — Grant, award, or other acquisition | +8,000 | SEC filing |
| 2026-05-27 | Sigal Charles Elliott · Director | Common Stock | A — Grant, award, or other acquisition | +8,000 | SEC filing |
| 2026-05-27 | BISCHOFBERGER NORBERT W · Director | Common Stock | A — Grant, award, or other acquisition | +8,000 | SEC filing |
| 2026-05-27 | Sigal Charles Elliott · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +16,000 | SEC filing |
| 2026-05-27 | MORE ROBERT J · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +16,000 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-29 | De Backer Marianne · President and CEO | Common Stock | J — Other acquisition or disposition | −233,532 | SEC filing |
| 2026-04-29 | De Backer Marianne · President and CEO | Common Stock | J — Other acquisition or disposition | +233,532 | SEC filing |
| 2026-03-20 | O'Byrne Jason · EVP & Chief Financial Officer | Common Stock | J — Other acquisition or disposition | −2,500 | SEC filing |
| 2026-03-20 | O'Byrne Jason · EVP & Chief Financial Officer | Common Stock | J — Other acquisition or disposition | +2,500 | SEC filing |
| 2025-06-09 | MORE ROBERT J · Director | Common Stock | J — Other acquisition or disposition | +14,027 | SEC filing |
| 2025-06-09 | MORE ROBERT J · Director | Common Stock | J — Other acquisition or disposition | −14,027 | SEC filing |
| 2025-06-06 | BISCHOFBERGER NORBERT W · Director | Common Stock | J — Other acquisition or disposition | +10,667 | SEC filing |
| 2025-06-06 | BISCHOFBERGER NORBERT W · Director | Common Stock | J — Other acquisition or disposition | −10,667 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.